Veru Announces Presentation of Phase 2 Study of Enobosarm — a Selective Androgen Receptor Targeting Agent in Metastatic AR+ER+HER2- Breast Cancer at 2021 ESMO Breast Cancer Congress

Frank Burrell
Scientific Storytelling

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing

Brenda Snow
Authentic Patient Voice

Paul Theisen
Patient Acquisition

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

David Linetsky
Point-of-Care Marketing

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs